Logo for Cytosorbents Corporation

Cytosorbents Investor Relations Material

Latest events

Logo for Cytosorbents Corporation

Q4 2024

Cytosorbents
Logo for Cytosorbents

Q4 2024

31 Mar, 2025
Logo for Cytosorbents

Q3 2024

7 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Cytosorbents Corporation

Access all reports
Cytosorbents Corporation is a medical device company specializing in blood purification technologies. The company develops and markets the CytoSorb adsorber, a device designed to reduce harmful substances such as cytokines, toxins, and metabolic waste from the bloodstream. These technologies are used in critical care and cardiac surgery applications to manage conditions like sepsis, inflammation, and organ failure. The company is headquartered in Princeton, New Jersey, and its shares are listed on the NASDAQ.